ABL Texcell Diagnostics SA (EPA:ABLD)

France · Delayed Price · Currency is EUR

2.380

-0.020 (-0.83%)

Oct 22, 2026, 3:37 PM CEST

ABL Texcell Diagnostics Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	11.13	7.97	5.87	6.19	9.36	-
Revenue Growth	39.71%	35.71%	-5.16%	-33.89%	-	-
Gross Profit	3.58	2.4	1.55	1.12	3.09	-0.1
Operating Income	1.5	0.32	-0.49	-0.66	0.06	-0.1
Net Income	1.98	0.99	0.29	0.05	1.11	0.26
Earnings Per Share	-	0.06	0.02	0.00	0.07	0.13
EPS Growth	-	200.00%	492.94%	-95.18%	-45.53%	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
France	2.1	2.1	1.82
Europe (Excluding France)	2.49	2.49	2.52
United States of America	0.28	0.28	0.06
Other Areas	2.09	2.08	0.94
Total	6.95	6.95	5.33

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	0.85	1.32	0.53	2.23	1.01	2.7
Total Debt	1.81	2.25	2.55	3.47	2.66	0
Net Cash (Debt)	-0.96	-0.93	-2.02	-1.24	-1.64	2.7
Net Cash Growth	-	-	-	-	-	14.55%
Net Cash Per Share	-	-0.06	-0.14	-0.08	-0.10	1.35

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	2.67	1.51	-1.35	-	-	-0.06
Capital Expenditures	-0.9	-0.79	-0.96	-	-	-
Free Cash Flow	1.76	0.71	-2.32	-	-	-0.06
Free Cash Flow Growth	146.39%	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	32.20%	30.15%	26.34%	18.05%	33.06%	-
Operating Margin	13.46%	3.98%	-8.36%	-10.62%	0.63%	-
Pretax Margin	12.95%	4.13%	-7.44%	-10.08%	5.24%	-
Profit Margin	17.77%	12.39%	4.86%	0.88%	11.81%	-
FCF Margin	15.82%	8.97%	-39.45%	-	-	-

Dividends

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Dividend Per Share	0.110	0.110	0.050
Dividend Per Share Growth	120.00%	120.00%	-
Dividend Yield	4.62%	3.66%	2.03%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	19.34	48.99	139.01	2875.26	26.23	15.47
Forward PE	-	87.50	20.50	-	-	-
P/FCF Ratio	21.72	67.63	-	-	-	-
PS Ratio	3.44	6.07	6.75	25.26	3.10	-